144 related articles for article (PubMed ID: 26607462)
1. Furanodiene enhances the anti-cancer effects of doxorubicin on ERα-negative breast cancer cells in vitro.
Zhong ZF; Qiang WA; Wang CM; Tan W; Wang YT
Eur J Pharmacol; 2016 Mar; 774():10-9. PubMed ID: 26607462
[TBL] [Abstract][Full Text] [Related]
2. Furanodiene, a natural small molecule suppresses metastatic breast cancer cell migration and invasion in vitro.
Zhong Z; Tan W; Chen X; Wang Y
Eur J Pharmacol; 2014 Aug; 737():1-10. PubMed ID: 24824922
[TBL] [Abstract][Full Text] [Related]
3. Furanodiene enhances tamoxifen-induced growth inhibitory activity of ERa-positive breast cancer cells in a PPARγ independent manner.
Zhong ZF; Li YB; Wang SP; Tan W; Chen XP; Chen MW; Wang YT
J Cell Biochem; 2012 Aug; 113(8):2643-51. PubMed ID: 22422660
[TBL] [Abstract][Full Text] [Related]
4. Furanodiene alters mitochondrial function in doxorubicin-resistant MCF-7 human breast cancer cells in an AMPK-dependent manner.
Zhong ZF; Tan W; Qiang WW; Scofield VL; Tian K; Wang CM; Qiang WA; Wang YT
Mol Biosyst; 2016 Apr; 12(5):1626-37. PubMed ID: 26987443
[TBL] [Abstract][Full Text] [Related]
5. Furanodiene, a natural product, inhibits breast cancer growth both in vitro and in vivo.
Zhong Z; Dang Y; Yuan X; Guo W; Li Y; Tan W; Cui J; Lu J; Zhang Q; Chen X; Wang Y
Cell Physiol Biochem; 2012; 30(3):778-90. PubMed ID: 22854281
[TBL] [Abstract][Full Text] [Related]
6. Sensitization and synergistic anti-cancer effects of Furanodiene identified in zebrafish models.
Zhu XY; Guo DW; Lao QC; Xu YQ; Meng ZK; Xia B; Yang H; Li CQ; Li P
Sci Rep; 2019 Mar; 9(1):4541. PubMed ID: 30872660
[TBL] [Abstract][Full Text] [Related]
7. Furanodienone inhibits cell proliferation and survival by suppressing ERα signaling in human breast cancer MCF-7 cells.
Li YW; Zhu GY; Shen XL; Chu JH; Yu ZL; Fong WF
J Cell Biochem; 2011 Jan; 112(1):217-24. PubMed ID: 21069738
[TBL] [Abstract][Full Text] [Related]
8. Combined effects of furanodiene and doxorubicin on the migration and invasion of MDA-MB-231 breast cancer cells in vitro.
Zhong ZF; Tan W; Tian K; Yu H; Qiang WA; Wang YT
Oncol Rep; 2017 Apr; 37(4):2016-2024. PubMed ID: 28184941
[TBL] [Abstract][Full Text] [Related]
9. Activation of ALDH1A1 in MDA-MB-468 breast cancer cells that over-express CYP2J2 protects against paclitaxel-dependent cell death mediated by reactive oxygen species.
Allison SE; Chen Y; Petrovic N; Zhang J; Bourget K; Mackenzie PI; Murray M
Biochem Pharmacol; 2017 Nov; 143():79-89. PubMed ID: 28756208
[TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
[TBL] [Abstract][Full Text] [Related]
11. Rhinacanthin-C enhances doxorubicin cytotoxicity via inhibiting the functions of P-glycoprotein and MRP2 in breast cancer cells.
Chaisit T; Siripong P; Jianmongkol S
Eur J Pharmacol; 2017 Jan; 795():50-57. PubMed ID: 27916559
[TBL] [Abstract][Full Text] [Related]
12. Furanodiene Induces Extrinsic and Intrinsic Apoptosis in Doxorubicin-Resistant MCF-7 Breast Cancer Cells via NF-κB-Independent Mechanism.
Zhong ZF; Yu HB; Wang CM; Qiang WA; Wang SP; Zhang JM; Yu H; Cui L; Wu T; Li DQ; Wang YT
Front Pharmacol; 2017; 8():648. PubMed ID: 28959205
[TBL] [Abstract][Full Text] [Related]
13. Indole-3-carbinol and its N-alkoxy derivatives preferentially target ERα-positive breast cancer cells.
Caruso JA; Campana R; Wei C; Su CH; Hanks AM; Bornmann WG; Keyomarsi K
Cell Cycle; 2014; 13(16):2587-99. PubMed ID: 25486199
[TBL] [Abstract][Full Text] [Related]
14. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
15. Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines.
Kim J; Lee J; Jang SY; Kim C; Choi Y; Kim A
Oncol Rep; 2016 May; 35(5):2553-60. PubMed ID: 26986571
[TBL] [Abstract][Full Text] [Related]
16. Different anticancer effects of Saxifragifolin A on estrogen receptor-positive and estrogen receptor-negative breast cancer cells.
Kim KH; Kim JY; Kwak JH; Pyo S
Phytomedicine; 2015 Aug; 22(9):820-8. PubMed ID: 26220629
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk of ROS/RNS and autophagy in silibinin-induced apoptosis of MCF-7 human breast cancer cells in vitro.
Zheng N; Liu L; Liu WW; Li F; Hayashi T; Tashiro SI; Onodera S; Ikejima T
Acta Pharmacol Sin; 2017 Feb; 38(2):277-289. PubMed ID: 27867187
[TBL] [Abstract][Full Text] [Related]
18. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
[TBL] [Abstract][Full Text] [Related]
19. 5-Acetyl goniothalamin suppresses proliferation of breast cancer cells via Wnt/β-catenin signaling.
Boonmuen N; Thongon N; Chairoungdua A; Suksen K; Pompimon W; Tuchinda P; Reutrakul V; Piyachaturawat P
Eur J Pharmacol; 2016 Nov; 791():455-464. PubMed ID: 27640746
[TBL] [Abstract][Full Text] [Related]
20. Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism.
Goodman CR; Sato T; Peck AR; Girondo MA; Yang N; Liu C; Yanac AF; Kovatich AJ; Hooke JA; Shriver CD; Mitchell EP; Hyslop T; Rui H
Oncogene; 2016 Mar; 35(11):1373-85. PubMed ID: 26096934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
